Agilent Technologies, Inc. $A Shares Sold by Mengis Capital Management Inc.

Key Points

• Mengis Capital Management Inc. has reduced its holdings in Agilent Technologies by 44.9%, now owning 12,414 shares valued at approximately $1.47 million.
• Agilent Technologies reported a revenue of $1.74 billion for the last quarter, exceeding analysts' expectations, and has set its FY 2025 earnings guidance between $5.560 and $5.590 EPS.
• Several analysts have recently upgraded Agilent's ratings, with Barclays increasing the price target from $125 to $150, and a consensus rating of "Moderate Buy" with an average price target of $148.69.

Mengis Capital Management Inc. reduced its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 44.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,414 shares of the medical research company's stock after selling 10,100 shares during the period. Mengis Capital Management Inc.'s holdings in Agilent Technologies were worth $1,465,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the business. IFP Advisors Inc increased its position in Agilent Technologies by 139.8% during the 2nd quarter. IFP Advisors Inc now owns 1,067 shares of the medical research company's stock valued at $126,000 after buying an additional 622 shares in the last quarter. Callan Family Office LLC increased its position in Agilent Technologies by 75.0% during the 2nd quarter. Callan Family Office LLC now owns 13,962 shares of the medical research company's stock valued at $1,648,000 after buying an additional 5,984 shares in the last quarter. Blair William & Co. IL increased its position in Agilent Technologies by 0.9% during the 2nd quarter. Blair William & Co. IL now owns 36,535 shares of the medical research company's stock valued at $4,312,000 after buying an additional 343 shares in the last quarter. Allegiance Financial Group Advisory Services LLC purchased a new stake in Agilent Technologies during the 2nd quarter valued at about $230,000. Finally, Vontobel Holding Ltd. grew its stake in Agilent Technologies by 12.7% during the 2nd quarter. Vontobel Holding Ltd. now owns 21,916 shares of the medical research company's stock valued at $2,586,000 after purchasing an additional 2,472 shares during the last quarter.

Wall Street Analyst Weigh In

Several analysts have weighed in on A shares. Robert W. Baird boosted their price target on Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a research note on Thursday, August 28th. Weiss Ratings reiterated a "hold (c)" rating on shares of Agilent Technologies in a research note on Wednesday. Rothschild Redb upgraded Agilent Technologies to a "strong-buy" rating in a research note on Wednesday. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Friday, October 3rd. Finally, Barclays boosted their price target on Agilent Technologies from $125.00 to $150.00 and gave the company an "equal weight" rating in a research note on Thursday, October 2nd. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $148.69.

Agilent Technologies Stock Performance

Shares of A stock opened at $140.13 on Friday. The company has a market capitalization of $39.73 billion, a P/E ratio of 32.89, a P/E/G ratio of 4.60 and a beta of 1.26. The business's 50 day moving average is $124.58 and its two-hundred day moving average is $116.94. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting analysts' consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. During the same quarter in the prior year, the firm earned $1.32 earnings per share. The business's revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies's dividend payout ratio is presently 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.